Veeda Clinical Research IPO GMP, Veeda Clinical Research Grey Market Premium Today
Know everything about Veeda Clinical Research IPO: Veeda Clinical Research IPO GMP (Veeda Clinical Research Grey Market Premium), Veeda Clinical Research IPO Date, Veeda Clinical Research IPO Review, Veeda Clinical Research IPO Benefits & Risks. We will update Veeda Clinical Research GMP daily. Also, all information related to Veeda Clinical Research IPO like price band, all dates, issue size and retail parts etc. All the important information about Veeda Clinical Research IPO is given below.
Veeda Clinical Research IPO
Vida Clinical Research Limited has emerged as one of India's leading independent full-service clinical research organizations ("CROs") based on revenue (as on March 31, 2020). The IPO of Veeda Clinical Research Limited is expected in 2022. Veeda Clinical Research Ltd Has filed its DRHP (Draft Red Herring Prospectus) with market regulator SEBI (Securities and Exchange Board of India) to raise around Rs 831.60 crore through IPO (Initial public offering).
Veeda Clinical Research IPO will open on January 2022 and close on January 2022. The price band of the Veeda Clinical Research IPO is ₹- to ₹-. The company is looking to raise around ₹831.60 crores through an initial public offering (IPO). Veeda Clinical Research IPO QIB quota is 75%, NII quota is 15% and RII quota is 10%. Veeda Clinical Research IPO listing date is - January 2022. Veeda Clinical Research Limited IPO GMP (Grey Market Premium) is given below.
Veeda Clinical Research Limited has given excellent financial performance. The company has made a profit of ₹62.97 crores in the financial year 2021. Veeda Clinical Research IPO Size is ₹831.60 crores. In this IPO, approx ₹500 Crores will be sold under OFS (Offer for sale) and the rest (Approx ₹331.60 Crores) will be sold under fresh issue. The IPO of Veeda Clinical Research will be listed on NSE and BSE. Veeda Clinical Research IPO face value is ₹- per equity share.
We will talk about Veeda Clinical Research's financial, benefits, and risks of investing in the company.
Read About
What is Veeda Clinical Research IPO GMP Today?
Veeda Clinical Research IPO GMP is ₹.
What is the Veeda Clinical Research IPO Date?
Veeda Clinical Research IPO Opening date is January 2022.
What is Veeda Clinical Research IPO Expected Return?
Veeda Clinical Research IPO Expected Returns is approx -%.
About Veeda Clinical Research Limited
Vida Clinical Research Limited (earlier known as Vida Clinical Research Private Limited) was established in India in the year 2004. The company is one of the largest independent clinical research organizations with a vision to build a CRO with in-depth scientific know-how, technological edge.
Vida Clinical Research Limited is a full-service independent global CRO (Clinical Research Organization). Vida Clinical Research Limited worked closely with its subsidiary, Bionids India Pvt Ltd ("Bionids"), and its joint venture, Ingenuity Biosciences Pvt Ltd ("Ingenuity"). The company provides a comprehensive portfolio of clinical, preclinical, and bio/analytical services to support the innovative, biosimilar, and generic drug development programs of global clients.
As of 31 March 2020, Vida Clinical Research Limited has carved out a niche as one of India's leading independent full-service clinical research organizations ("CROs") by revenue. BioNeeds is a preclinical clinical research organization (CRO) that provides development and regulatory services in the pharmaceutical sector.
We are an independent and professionally managed contract research group offering scientific leadership, global quality management systems, and long-term operational and financial stability through our technology and deep investment. The company is committed to the quality of its products.
In addition, the company serves customers globally in the following industries:
- Medical devices
- Herbal/Nutraceuticals
- Agricultural Chemicals and Industrial Chemicals
- Pharmaceutical and Biopharmaceutical
Check out our new tool Stock Average Calculator.
Important Links:
- Veeda Clinical Research Website
- Veeda Clinical Research DRHP
- Veeda Clinical Research RHP
Purpose of the offer
- To prepay/repay all or a part of the dues raised by the company.
- To serve the general corporate purpose.
Veeda Clinical Research GMP Today (Grey Market Premium)
[Note: Veeda Clinical Research Ltd IPO GMP has not started yet]
| DATE | GMP | KOSTAK | Subject to Sauda |
|---|---|---|---|
| January | ₹ | ₹ | ₹ |
| January | ₹ | ₹ | ₹ |
| January | ₹ | ₹ | ₹ |
| January | ₹ | ₹ | ₹ |
| January | ₹ | ₹ | ₹ |
| January | ₹ | ₹ | ₹ |
| January | ₹ | ₹ | ₹ |
| January | ₹ | ₹ | ₹ |
| January | ₹ | ₹ | ₹ |
| January | ₹ | ₹ | ₹ |
| January | ₹ | ₹ | ₹ |
Veeda Clinical Research IPO Date and Price Band Details
Veeda Clinical Research IPO open date: January 2022, Closing date: January 2022, and Listing date: January 2022. The price band of Veeda Clinical Research IPO is ₹- to ₹-per share. Veeda Clinical Research IPO issue size is Rs 831.60 crores. Veeda Clinical Research Ipo retails portion is 10%, QIB Portion is 75%, and NII Portion is 15%.
| IPO Open: | January 2022 |
| IPO Close: | January 2022 |
| Listing Date: | January 2022 |
| Listing On: | NSE & BSE |
| IPO Size: | Approx ₹831.60 Crores |
| Fresh Issue: | Approx ₹331.60 Crores |
| Offer For Sale: | Approx ₹500 Crores |
| Price Band: | ₹- to ₹- per share |
| Face Value: | ₹10 per Equity share |
| QIB Portion: | 50% |
| Retail Portion: | 35% |
| NII Portion: | 15% |
| Employee Res: | Not Disclosed |
Veeda Clinical Research IPO Market Lot & Size
Veeda Clinical Research IPO's minimum lot size is - shares with ₹- application amount and the maximum lot size are - shares with ₹- application amount.
| Minimum Lot: | 01 |
| Minimum Lot Size: | - Shares |
| Minimum Amount: | ₹- |
| Maximum Lot: | 13 |
| Maximum Lot Size: | - Shares |
| Maximum Amount: | ₹- |
Veeda Clinical Research IPO Allotment & Listing Date
| Ipo Opening Date: | January 2022 |
| IPO Closing Date: | January 2022 |
| Basis of Allotment: | January 2022 |
| Refund Date: | January 2022 |
| Credit to Demat Account: | January 2022 |
| Listing Date: | January 2022 |
Veeda Clinical Research IPO Review
HappiestPost View: To be updated.
Brokerage Firm IPO Reviews
- Motilal Oswal: To be updated
- ICICI Securities: To be updated
- Capital Market: To be updated
- Ventura Securities Limited: To be updated
- GEPL Capital Ltd: To be updated soon
Veeda Clinical Research Ipo Review
[Not rated yet (To be updated)]
Review For Listing Gain
Review For Short term
Review For Long term
Strength
- Veeda Clinical Research Limited is one of the largest full-service independent CROs in India.
- The company has an extensive sales network and market reach.
- The company has a long-standing relationship with its customers.
- The company has a worldwide customer base with a high level of customer centricity and satisfaction.
- The company has professional management and a hugely experienced team.
- The company has a track record of consistently strong financial success.
- The company is expanding its reach in regulated markets not only in India but also in the USA and Europe.
- The company is focusing on the development and discovery of new drugs.
- The success of a clinical trial is driven by the strategic selection of a credible CRO.
- The company has a comprehensive portfolio of clinical research services to support diverse needs.
Risks
- The Company may suffer losses if the Company is unable to successfully develop and sell new services.
- Failure of the company to develop or implement new technology can have a negative impact on the company.
- The company depends on other companies for some raw materials, which may cause a temporary interruption or shortfall in the supply of raw materials that may have a negative impact on the company's operations and business.
- A big question is whether the company will be able to sustain its growth in the coming years or not.
- The promoters of the company and their directors are subject to legal proceedings. Any bad result could be for their company.
- The impact of the COVID-19 pandemic on his company is still unknown.
Veeda Clinical Research Financials
Veeda Clinical Research Financials(in Crores)
| Year | Total Assets | Revenue | Profit |
|---|---|---|---|
| 2019 | ₹154.73 | ₹223.97 | ₹44.16 |
| 2020 | ₹- | ₹- | ₹- |
| 2021 | ₹285.18 | ₹234.38 | ₹62.97 |
Promoters
The promoters of the company are:
- Basil Private Limited
Contact Details of Veeda Clinical Research
Veeda Clinical Research Limited
Shivalik Plaza – A, 2nd Floor,
Opposite Ahmedabad Management Association, Ambawadi,
Ahmedabad 380 015 Gujarat, India
Tel: +91 79 6777 3000
E-mail: investor.relation@veedacr.com
Website: www.veedacr.com
Veeda Clinical Research Lead Managers
- JM Financial Limited
- ICICI Securities Limited
- SBI Capital Markets Limited
- Systematix Corporate Services Limited
Veeda Clinical Research IPO Registrars
Link Intime India Private Limited
C-101, 1st Floor, 247 Park
Lal Bahadur Shastri Marg, Vikhroli (West)
Mumbai 400 083
Maharashtra, India
Tel: +91 22 4918 6200
E-mail: veeda.ipo@linkintime.co.in
Website: www.linkintime.co.in
Conclusion
They are India’s leading independent full-service clinical research organizations (“CRO”) on the basis of revenue. Considering the financial position of the company, Veeda Clinical Research Limited has an excellent financial track record. The company has made a profit of ₹62.97 crores in the financial year 2021. Our suggestion will be updated when the Veeda Clinical Research IPO price band and other IPO details are announced. Veeda Clinical Research Limited's financial statement and other information are provided above.
Veeda Clinical Research IPO FAQs
What is Veeda Clinical Research IPO GMP Today?
Veeda Clinical Research IPO GMP is ₹- as of today.
What is Veeda Clinical Research IPO Opening Date?
Veeda Clinical Research IPO Opening date is January 2022.
What is the Veeda Clinical Research IPO Closing Date?
Veeda Clinical Research IPO Closing date is January 2022.
What is the Veeda Clinical Research IPO Allotment date?
Veeda Clinical Research IPO Allotment Date is January 2022.
What is Veeda Clinical Research IPO Listing Date?
Veeda Clinical Research IPO Date is January 2022.
What is Veeda Clinical Research IPO Kostak Rate?
Veeda Clinical Research IPO Kostak rate is ₹-.
What is Veeda Clinical Research IPO Expected Returns?
Veeda Clinical Research IPO Expected Returns is -%.
Read More:
For other important information related to the stock market and Grey Market Premium, Costak rate, you can click on the links given below.
How to Apply the Veeda Clinical Research Ltd IPO with Zerodha?
1. Open your Zerodha kite app and visit the Account tab, then see for console and click on IPO.
2. If you are a Desktop user then Log in to Console on Zerodha Website. Go to Portfolio and Click on IPO.
3. You will see the IPO name "Veeda Clinical Research Ltd".
4. Then, Click on Bid Button.
5. Then, Enter your UPI ID.
6. Then, Fill in Quantity and Price. (we recommend, you should choose the cutoff price.)
7. Then Submit the IPO Application Form.
8. Now go to your UPI App (PhonePe, Google Pay, etc) or BHIM App to Approve the mandate.
7. Then Submit the IPO Application Form.
8. Now go to your UPI App (PhonePe, Google Pay, etc) or BHIM App to Approve the mandate.
Disclaimer
- We are not involved in gray market trading in any way. And do not provide the facility to buy or sell any IPO from IPO.
- Reference to IPO Grey Market Premium (IPO GMP) is valid only for the date specified in the header.
- We are not involved in the buying or selling of IPO form.
- Do not decide to subscribe to an IPO solely based on GMP (Grey Market Premium), as this can change at any time. Research the fundamentals and financial statements of companies before subscribing.
We hope you like this article about Veeda Clinical Research IPO. If you have a query about Veeda Clinical Research IPO Please post a comment.
Thanks For Visiting & Happy Investing.
0 Comments
We are waiting for your comments. 💙